Cargando…

Genome-wide identification of cancer-specific alternative splicing in circRNA

Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jing, Chen, Ke, Dong, Xin, Xu, Xiaolong, Jin, Yuxuan, Zhang, Xinyang, Chen, Wenbo, Han, Yujing, Shao, Lin, Gao, Yang, He, Chunjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408762/
https://www.ncbi.nlm.nih.gov/pubmed/30849979
http://dx.doi.org/10.1186/s12943-019-0996-0
_version_ 1783401842211815424
author Feng, Jing
Chen, Ke
Dong, Xin
Xu, Xiaolong
Jin, Yuxuan
Zhang, Xinyang
Chen, Wenbo
Han, Yujing
Shao, Lin
Gao, Yang
He, Chunjiang
author_facet Feng, Jing
Chen, Ke
Dong, Xin
Xu, Xiaolong
Jin, Yuxuan
Zhang, Xinyang
Chen, Wenbo
Han, Yujing
Shao, Lin
Gao, Yang
He, Chunjiang
author_sort Feng, Jing
collection PubMed
description Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-specific alternative splicing of circRNA is less likely to be identified. Here, we proposed a de novo algorithm, CircSplice, that could identify internal alternative splicing in circRNA and compare differential circRNA splicing events between different conditions (http://gb.whu.edu.cn/CircSplice or https://github.com/GeneFeng/CircSplice). By applying CircSplice in clear cell renal cell carcinoma and bladder cancer, we detected 4498 and 2977 circRNA alternative splicing (circ-AS) events in the two datasets respectively and confirmed the expression of circ-AS events by RT-PCR. We further inspected the distributions and patterns of circ-AS in cancer and adjacent normal tissues. To further understand the potential functions of cancer-specific circ-AS, we classified those events into tumor suppressors and oncogenes and performed pathway enrichment analysis. This study is the first comprehensive view of cancer-specific circRNA alternative splicing, which could contribute significantly to regulation and functional research of circRNAs in cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0996-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6408762
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64087622019-03-21 Genome-wide identification of cancer-specific alternative splicing in circRNA Feng, Jing Chen, Ke Dong, Xin Xu, Xiaolong Jin, Yuxuan Zhang, Xinyang Chen, Wenbo Han, Yujing Shao, Lin Gao, Yang He, Chunjiang Mol Cancer Letter to Editor Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-specific alternative splicing of circRNA is less likely to be identified. Here, we proposed a de novo algorithm, CircSplice, that could identify internal alternative splicing in circRNA and compare differential circRNA splicing events between different conditions (http://gb.whu.edu.cn/CircSplice or https://github.com/GeneFeng/CircSplice). By applying CircSplice in clear cell renal cell carcinoma and bladder cancer, we detected 4498 and 2977 circRNA alternative splicing (circ-AS) events in the two datasets respectively and confirmed the expression of circ-AS events by RT-PCR. We further inspected the distributions and patterns of circ-AS in cancer and adjacent normal tissues. To further understand the potential functions of cancer-specific circ-AS, we classified those events into tumor suppressors and oncogenes and performed pathway enrichment analysis. This study is the first comprehensive view of cancer-specific circRNA alternative splicing, which could contribute significantly to regulation and functional research of circRNAs in cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0996-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-08 /pmc/articles/PMC6408762/ /pubmed/30849979 http://dx.doi.org/10.1186/s12943-019-0996-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to Editor
Feng, Jing
Chen, Ke
Dong, Xin
Xu, Xiaolong
Jin, Yuxuan
Zhang, Xinyang
Chen, Wenbo
Han, Yujing
Shao, Lin
Gao, Yang
He, Chunjiang
Genome-wide identification of cancer-specific alternative splicing in circRNA
title Genome-wide identification of cancer-specific alternative splicing in circRNA
title_full Genome-wide identification of cancer-specific alternative splicing in circRNA
title_fullStr Genome-wide identification of cancer-specific alternative splicing in circRNA
title_full_unstemmed Genome-wide identification of cancer-specific alternative splicing in circRNA
title_short Genome-wide identification of cancer-specific alternative splicing in circRNA
title_sort genome-wide identification of cancer-specific alternative splicing in circrna
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408762/
https://www.ncbi.nlm.nih.gov/pubmed/30849979
http://dx.doi.org/10.1186/s12943-019-0996-0
work_keys_str_mv AT fengjing genomewideidentificationofcancerspecificalternativesplicingincircrna
AT chenke genomewideidentificationofcancerspecificalternativesplicingincircrna
AT dongxin genomewideidentificationofcancerspecificalternativesplicingincircrna
AT xuxiaolong genomewideidentificationofcancerspecificalternativesplicingincircrna
AT jinyuxuan genomewideidentificationofcancerspecificalternativesplicingincircrna
AT zhangxinyang genomewideidentificationofcancerspecificalternativesplicingincircrna
AT chenwenbo genomewideidentificationofcancerspecificalternativesplicingincircrna
AT hanyujing genomewideidentificationofcancerspecificalternativesplicingincircrna
AT shaolin genomewideidentificationofcancerspecificalternativesplicingincircrna
AT gaoyang genomewideidentificationofcancerspecificalternativesplicingincircrna
AT hechunjiang genomewideidentificationofcancerspecificalternativesplicingincircrna